The lack of rigorous evidence means that both efficacy and tolerability remain uncertain, and individual responses are highly unpredictable
All studies cited below are the work of their respective authors and institutions
The following candidates are options: Ala, Gln, or Glu
Meet our doctors Last reviewed: 05 Aug 2025 Sources Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity, JAMA [accessed 27 June 2025] Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity, JAMA Network Open [accessed 27 June 2025] Mounjaro KwikPen 10mg solution for injection in pre-filled pen (PIL), emc [accessed 26 June 2025] Tirzepatide Once Weekly for the Treatment of Obesity, The New England Journal of Medicine [accessed 26 June 2025] Keeping weight off: Mindfulness-Based Stress Reduction alters amygdala functional connectivity during weight loss maintenance in a randomized control trial, Public Library of Science [accessed 26 June 2025]
Ideal for those with active lifestyles or anyone looking for a daily boost
Odczynnik GLP-1 + GIP 5 mg PEN (RUO) nie jest tym lekiem i nie by przedmiotem tych bada
